Get the Stockscreener App
0.7615
16.32%
-0.1485
Pre-market:
.75
-0.0115
-1.51%
Onconetix Inc stock is traded at $0.7615, with a volume of 2.30M.
It is down -16.32% in the last 24 hours and down -71.96% over the past month.
Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of solutions for men's health and oncology. The company owns Proclarix, an in vitro diagnostic test for prostate cancer, approved for sale in the European Union. Additionally, it is focused on marketing Proclarix in the U.S. as a lab-developed product. Onconetix operates in one segment: commercial. Geographically, the company generates maximum revenue from Switzerland and the rest from the United Kingdom.
See More
Previous Close:
$0.91
Open:
$0.8149
24h Volume:
2.30M
Relative Volume:
0.44
Market Cap:
$527.66K
Revenue:
$815.40K
Net Income/Loss:
$-14.03M
P/E Ratio:
-0.00288
EPS:
-264.0465
Net Cash Flow:
$-9.68M
1W Performance:
-32.61%
1M Performance:
-71.96%
6M Performance:
-95.72%
1Y Performance:
-97.23%
1-Day Range:
$0.71
$0.8149
1-Week Range:
$0.671
$2.82
52-Week Range:
$0.671
$74.29
Onconetix Inc Stock (ONCO) Company Profile
Name
Onconetix Inc
Sector
Industry
Phone
513-620-4101
Address
201 E. FIFTH STREET, CINCINNATI
Compare ONCO vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ONCO
Onconetix Inc
|
0.7615 | 630.56K | 815.40K | -14.03M | -9.68M | -264.05 |
VRTX
Vertex Pharmaceuticals Inc
|
441.70 | 112.35B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
753.93 | 79.71B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
840.87 | 52.29B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
333.39 | 44.48B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
319.94 | 35.51B | 5.36B | 287.73M | 924.18M | 2.5229 |
Onconetix Inc Stock (ONCO) Latest News
What's going on with Onconetix shares on Friday? - MSN
Onconetix Stock Short Interest Rises to 98.42% - Quiver Quantitative
Onconetix Faces Market Shift Amid Strategic Stock Move - timothysykes.com
Pullback Watch: Does Onconetix Inc have a sustainable dividend2026 Winners & Losers & Safe Capital Growth Tips - baoquankhu1.vn
Onconetix stock skyrockets after Realbotix ships Vinci-equipped robot to Ericsson - MSN
Trending Stocks Today | Onconetix Soars 53.98% - Moomoo
Check out the stocks that are attracting the most attention and driving market activity. - ChartMill
Onconetix (ONCO) jumps 59% as reverse-split dynamics and Realbotix deal keep speculation elevated - Quiver Quantitative
Onconetix Stock Skyrockets After Realbotix Ships Vinci-Equipped Robot To Ericsson - Benzinga
Crude Oil Surges 3%; Neogen Shares Fall After Q3 Results - Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Which stocks are experiencing notable movement on Thursday? - ChartMill
Onconetix Expands with Realbotix AI Acquisition - timothysykes.com
Onconetix (ONCO) agrees to buy Realbotix; Vinci-equipped robot delivered to Ericsson - Stock Titan
Onconetix Highlights Realbotix's Launch of Vinci AI Vision System with Delivery of First Vinci-Equipped Humanoid Robot to Ericsson - ChartMill
Update Report: What are the risks of holding Onconetix IncQuarterly Market Review & Community Verified Trade Alerts - baoquankhu1.vn
Stock List: Research Stocks from Around the World - GuruFocus
Market Review: How does Onconetix Inc perform in inflationary periodsInsider Buying & Accurate Intraday Trading Signals - baoquankhu1.vn
ONCO SEC FilingsOnconetix 10-K, 10-Q, 8-K Forms - Stock Titan
Trade Report: Does AlphaVest Acquisition Corp Equity Right have a sustainable dividend2026 Decliners & Expert Verified Movement Alerts - baoquankhu1.vn
Aug Highlights: Is Onconetix Inc forming a double bottomRecession Risk & Risk Adjusted Buy/Sell Alerts - baoquankhu1.vn
Volume Summary: What is the long term forecast for Onconetix Inc stock2026 Intraday Action & Fast Moving Stock Trade Plans - baoquankhu1.vn
Onconetix Highlights Realbotix AI Humanoid Robot Delivery Update - Sahm
Realbotix expects to deliver 19 robots through May 2026 By Investing.com - Investing.com Australia
Onconetix (STU:J4T1) Cyclically Adjusted Price-to-FCF : (As of Apr. 02, 2026) - GuruFocus
Realbotix expects to deliver 19 robots through May 2026 - Investing.com
19 Robots Expected as Onconetix (NASDAQ: ONCO) Advances Realbotix Deal - Stock Titan
ONCO Dives 22.7% Amid Regulatory and Market Volatility—What's Next for Onconetix? - Bitget
Onconetix Inc Statistics – GETTEX:A426MU - TradingView — Track All Markets
Total revenue of Onconetix Inc – GETTEX:A426MU - TradingView
Cost of goods sold of Onconetix Inc – GETTEX:A426MU - TradingView
Onconetix CEO Karina Fedasz to step down, David White to succeed - TipRanks
3 Penny Stocks to Watch Now, 3/31/26 - TipRanks
Onconetix (ONCO) hires David White as CEO; Board adds Sammy Dorf as deal progresses - Stock Titan
Onconetix names David White CEO, adds Sammy Dorf to board By Investing.com - in.investing.com
Onconetix appoints David White as chief executive officer and Sammy Dorf as member of the board of directors - MarketScreener
Onconetix names David White CEO, adds Sammy Dorf to board - investing.com
Onconetix Appoints David White As Chief Executive Officer And Sammy Dorf As Member Of The Board Of Directors - TradingView
Onconetix Appoints David White as Chief Executive Officer and Sammy Dorf as Member of the Board of Directors - GlobeNewswire
Earnings Report: What is the long term forecast for Onconetix Inc stock2026 Selloffs & Weekly Chart Analysis and Guides - baoquankhu1.vn
Best Penny Stocks To Watch Now – March 29th - Defense World
Why is this micro-cap stock surging 50% in premarket? - MSN
Fund Flows: Why is Onconetix Inc stock going down2026 Key Lessons & High Accuracy Trade Alerts - baoquankhu1.vn
$Onconetix (ONCO.US)$ - moomoo.com
[DEF 14A] Onconetix, Inc. Definitive Proxy Statement - Stock Titan
Onconetix Inc Stock (ONCO) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.69%
0.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):